Lataa...

Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment

Multiple myeloma is a complex hematologic malignancy, and despite a survival improvement related to the growing number of available therapeutic options since 2000s, it remains an incurable disease with most patients experiencing relapse. However, therapeutic options for this disease are constantly e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmaceuticals (Basel)
Päätekijät: Morè, Sonia, Petrucci, Maria Teresa, Corvatta, Laura, Fazio, Francesca, Offidani, Massimo, Olivieri, Attilio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760536/
https://ncbi.nlm.nih.gov/pubmed/33260960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120426
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!